Pulmonology Articles

Pulmonology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Nave R - The unique pharmacokinetic and pharmacodynamic profile of ciclesonide offers a rationale that supports the favourable risk-benefit profile observed in clinical trials in patients with persistent asthma.

Related Articles

Clinical importance of identifying immunoglobulin E-mediated disease in patients with Asthma
Clinical Cornerstone, 10/01/09    Relevance Score: 96%

Bone mineral density and fractures in older men with chronic obstructive pulmonary disease or asthma
Osteoporosis International, 10/13/09    Relevance Score: 95%

The Saudi Initiative for asthma
Annals of Thoracic Medicine, 10/13/09    Relevance Score: 95%

Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study
Journal of Allergy and Clinical Immunology, 10/09/09    Relevance Score: 95%

Identification of Asthma Phenotypes using Cluster Analysis in the Severe Asthma Research Program
American Journal of Respiratory and Critical Care Medicine, 11/09/09    Relevance Score: 94%

Today in Asthma/Atopy...keeping you current

Pneumococcal carriage is more common in asthmatic than in non-asthmatic young men
The Clinical Respiratory Journal, 12/16/09

The effect of statin therapy on allergic patients with asthma
Annals of Allergy, Asthma, and Immunology, 12/16/09

Asthma Research Performance in Asia-Pacific: A Bibliometric Analysis by Searching PubMed Database
Journal of Asthma, 12/16/09

Today in Clinical Pharmacology...keeping you current

Oral Immunotherapy with inactivated NTHi reduces severity of acute exacerbations in severe COPD
Chest, 12/16/09

Use of oseltamivir in children
Canadian Family Physician, 12/16/09

Measuring exacerbations in obstructive lung disease
Pharmacoepidemiology and Drug Safety, 12/16/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address